Emollient clobetasol propionate 0.5 MG/ML Topical Cream — RxCUI 1992281
RxNorm drug concept · Semantic clinical drug
RxCUI 1992281
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1992281
Official nameEmollient clobetasol propionate 0.5 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclobetasol propionate 0.05 % Emollient Base Topical Cream
FDA products mapped4
Package NDCs mapped12
Reported Medicaid activity (SDUD)10,961 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clobetasol Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Clobetasol propionate shampoo is for moderate to severe scalp psoriasis in adults 18 and older. It is not for use on your face, groin or underarms.
- Apply a thin film to dry, affected scalp areas once a day. Leave it on for 15 minutes, then lather and rinse well. Wash your hands afterward and keep it away from your eyes and lip...
- No more than 4 consecutive weeks, and stop sooner if your psoriasis is controlled. If you are not better in 4 weeks, check in with your doctor.
- Burning, stinging, itching, dryness and acne-like bumps are the most common. Call your doctor if irritation is severe, you see signs of infection, or you notice eye pain or blurred...
🕸️ Concept Web — How Emollient clobetasol propionate 0.5 MG/ML Topica... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Emollient clobetasol propionate 0.5 MG/ML Topical Cream
RxCUI 1992281 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Clobetasol
2590IN -
Clobetasol propionate
21245PIN
-
Clobetasol
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clobetasol Topical Cream
562031SCDF -
Clobetasol propionate Topical Cream
2646599SCDFP -
Clobetasol Topical Product
1153083SCDG -
Clobetasol propionate Topical Product
2659863SCDGP -
Topical Cream
316982DF -
Topical Product
1151122DFG
-
Clobetasol Topical Cream
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clobetasol propionate 0.5 MG/ML
861352SCDC
-
Clobetasol propionate 0.5 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clobetasol propionate 0.5 MG/ML
SCDC · 861352 -
Clobetasol Topical Cream
SCDF · 562031 -
Clobetasol propionate Topical Cream
SCDFP · 2646599 -
Clobetasol Topical Product
SCDG · 1153083 -
Clobetasol propionate Topical Product
SCDGP · 2659863
📦 FDA Products & Package NDCs
4 products · 12 package NDCs
12 package NDCs map to RxCUI 1992281 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00168-0301-15 | 1 TUBE in 1 CARTON (0168-0301-15) / 15 g in 1 TUBE | Clobetasol Propionate (emollient) | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 1999-05-26 |
| 00168-0301-30 | 1 TUBE in 1 CARTON (0168-0301-30) / 30 g in 1 TUBE | Clobetasol Propionate (emollient) | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 1999-05-26 |
| 00168-0301-60 | 1 TUBE in 1 CARTON (0168-0301-60) / 60 g in 1 TUBE | Clobetasol Propionate (emollient) | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 1999-05-26 |
| 51672-1297-01 | 1 TUBE in 1 CARTON (51672-1297-1) / 15 g in 1 TUBE | Clobetasol Propionate | Sun Pharmaceutical Industries, Inc. | 2000-05-17 |
| 51672-1297-02 | 1 TUBE in 1 CARTON (51672-1297-2) / 30 g in 1 TUBE | Clobetasol Propionate | Sun Pharmaceutical Industries, Inc. | 2000-05-17 |
| 51672-1297-03 | 1 TUBE in 1 CARTON (51672-1297-3) / 60 g in 1 TUBE | Clobetasol Propionate | Sun Pharmaceutical Industries, Inc. | 2000-05-17 |
| 72162-2628-02 | 1 TUBE in 1 CARTON (72162-2628-2) / 15 g in 1 TUBE | Clobetasol Propionate (emollient) | Bryant Ranch Prepack | 2026-04-23 |
| 72162-2628-03 | 1 TUBE in 1 CARTON (72162-2628-3) / 30 g in 1 TUBE | Clobetasol Propionate (emollient) | Bryant Ranch Prepack | 2026-04-23 |
| 72162-2628-06 | 1 TUBE in 1 CARTON (72162-2628-6) / 60 g in 1 TUBE | Clobetasol Propionate (emollient) | Bryant Ranch Prepack | 2026-04-23 |
| 83148-0064-15 | 1 TUBE in 1 CARTON (83148-064-15) / 15 g in 1 TUBE | Clobetasol Propionate (emollient) | The J. Molner Company LLC | 2025-09-29 |
| 83148-0064-30 | 1 TUBE in 1 CARTON (83148-064-30) / 30 g in 1 TUBE | Clobetasol Propionate (emollient) | The J. Molner Company LLC | 2025-10-01 |
| 83148-0064-60 | 1 TUBE in 1 CARTON (83148-064-60) / 60 g in 1 TUBE | Clobetasol Propionate (emollient) | The J. Molner Company LLC | 2025-09-29 |
Observed labelers:
Bryant Ranch Prepack (3) ·
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. (3) ·
Sun Pharmaceutical Industries, Inc. (3) ·
The J. Molner Company LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.6108
Range $0.5620–$0.6402
· middle 50% $0.5916–$0.6321
· 8 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.